Vivos Therapeutics Inc (VVOS)

04:58 AM

Vivos Therapeutics (NASDAQ:VVOS) Cut to Sell at Wall Street Zen - Defense World

04:58 AM

May 23, 2025

Vivos Therapeutics (NASDAQ:VVOS) Stock Rating Lowered by Alliance Global Partners - Defense World

May 23, 2025

May 23, 2025

Vivos Issues $1.1 Million Convertible Promissory Note - marketscreener.com

May 23, 2025

May 23, 2025

Vivos Therapeutics Secures $1.1M Convertible Note - TipRanks

May 23, 2025

May 23, 2025

Vivos Therapeutics (NASDAQ:VVOS) Cut to “Hold” at Alliance Global Partners - Defense World

May 23, 2025

May 22, 2025

Vivos Therapeutics signals transformative growth with SCN acquisition and expects positive cash flow by end of 2025 - MSN

May 22, 2025

May 20, 2025

Vivos Therapeutics (VVOS) Downgraded Amidst Business Model Challenges | VVOS Stock News - GuruFocus

May 20, 2025

May 18, 2025

Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today - MSN

May 18, 2025

May 16, 2025

Vivos Therapeutics’ Earnings Call: Strategic Shifts Amid Financial Challenges - TipRanks

May 16, 2025

May 16, 2025

Vivos Therapeutics Shifts Strategy Amid Financial Results - TipRanks

May 16, 2025

May 15, 2025

Earnings call transcript: Vivos Therapeutics reports Q1 2025 earnings, stock rises - Investing.com Nigeria

May 15, 2025

May 15, 2025

Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates - sharewise

May 15, 2025

May 15, 2025

Vivos Therapeutics Q1 2025 Financial Results - TradingView

May 15, 2025

May 15, 2025

Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update - The Manila Times

May 15, 2025

May 15, 2025

Vivos Therapeutics Transforms Business Model with $9M Sleep Center Deal as Product Sales Rise - Stock Titan

May 15, 2025

May 14, 2025

Vivos to Report First Quarter Results - Dentistry Today

May 14, 2025

May 14, 2025

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call - The Manila Times

May 14, 2025

May 14, 2025

Vivos Therapeutics, Inc. to Release First Quarter 2025 Financial Results on May 15, 2025 - Nasdaq

May 14, 2025

May 14, 2025

Sleep Apnea Tech Leader Vivos Therapeutics Reports Q1 2025 Earnings TomorrowKey Details Here - Stock Titan

May 14, 2025

May 11, 2025

Vivos Therapeutics (VVOS) to Release Quarterly Earnings on Tuesday - Defense World

May 11, 2025

May 09, 2025

Vivos Therapeutics Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView

May 09, 2025

May 07, 2025

Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - MSN

May 07, 2025

May 04, 2025

Geode Capital Management LLC Grows Stock Holdings in Vivos Therapeutics, Inc. (NASDAQ:VVOS) - Defense World

May 04, 2025

Apr 23, 2025

Veterinary Cancer Breakthrough: Vivos Reports 150% Growth, Expands Novel Treatment to Horses - Stock Titan

Apr 23, 2025

Apr 18, 2025

In brief: Revelstoke recaps AOM, Vivos to make buy, state legislation makes tracks - HME News

Apr 18, 2025

Apr 17, 2025

Healthcare Stocks Take A Hit Despite Abbott's Earnings Beat - Finimize

Apr 17, 2025

Apr 16, 2025

Vivos Therapeutics to acquire operating assets of The Sleep Center of Nevada - MSN

Apr 16, 2025

Apr 16, 2025

Vivos Therapeutics to Acquire The Sleep Center of Nevada - marketscreener.com

Apr 16, 2025

Apr 16, 2025

Vivos Opens New Sleep Center - Baystreet.ca

Apr 16, 2025

Apr 16, 2025

Vivos Therapeutics announces agreement to acquire operating assets of SCN - TipRanks

Apr 16, 2025

Apr 16, 2025

Vivos To Acquire Operating Assets Of The Sleep Center Of Nevada - Nasdaq

Apr 16, 2025

Apr 16, 2025

Vivos Therapeutics Signs Definitive Agreement To Acquire Largest Sleep Center Operator In Nevada - marketscreener.com

Apr 16, 2025

Apr 16, 2025

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada - The Manila Times

Apr 16, 2025

Apr 16, 2025

Major Healthcare Expansion: Vivos Takes Over Nevada Sleep Giant Serving 3,000 Monthly Patients - Stock Titan

Apr 16, 2025

Apr 12, 2025

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Report on Q2 2024 Financial Results, Operational Update - MSN

Apr 12, 2025

Apr 11, 2025

Commonwealth Equity Services LLC Buys 5,000 Shares of Vivos Therapeutics, Inc. (NASDAQ:VVOS) - Defense World

Apr 11, 2025

Apr 05, 2025

Positive Sentiment Still Eludes Vivos Therapeutics, Inc. (NASDAQ:VVOS) Following 26% Share Price Slump - simplywall.st

Apr 05, 2025

Apr 03, 2025

Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress - ACCESS Newswire

Apr 03, 2025

Apr 03, 2025

Vivos Therapeutics Inc (VVOS) Q4 2024 Earnings Call Highlights: Strategic Shifts Propel Revenue ... By GuruFocus - Investing.com Canada

Apr 03, 2025

Apr 02, 2025

Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates - MSN

Apr 02, 2025

Apr 02, 2025

Vivos Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Apr 02, 2025

Apr 01, 2025

Vivos Therapeutics’ Earnings Call Highlights Growth and Expansion - TipRanks

Apr 01, 2025

Apr 01, 2025

Vivos Therapeutics (VVOS) Grows Revenue by 26% and Cuts Operatin - GuruFocus

Apr 01, 2025

Apr 01, 2025

Vivos Therapeutics price target lowered to $5.50 from $6 at Alliance Global Partners - TipRanks

Apr 01, 2025

Apr 01, 2025

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025

Apr 01, 2025

Vivos Therapeutics Reports Revenue Growth and Strategic Shift - TipRanks

Apr 01, 2025